Compare Alliant Energy Corporation (LNT) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alliant Energy Corporation vs Repligen Corporation Common Stock — how do they compare? Alliant Energy Corporation trades at $67.7 (market cap $17.51B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B). The key difference: Alliant Energy Corporation is the larger of the two by market cap, and Alliant Energy Corporation pays a 3.17% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Alliant Energy Corporation for 65 Days and Repligen Corporation Common Stock for 0 Days on average.
| LNT | RGEN | |
|---|---|---|
Market Cap | $17.51B | $11.31B |
Volume | 2,397,331 | 1,216,919 |
Sector | Utilities | Health |
52-Week High | $78.03 | $194.57 |
52-Week Low | $63.21 | $102.87 |
Typical Hold Time | 65 Days | 0 Days |
Enterprise Value | $29.60B | $11.20B |
Dividend Yield | 3.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LNT trades at $66.96, up 0.75% today, with a bullish technical signal despite mixed momentum indicators. The company shows strong fundamentals with Q2 2026 EPS beating expectations at $0.65 versus $0.579, and revenue growth to $4.36B in 2025. Recent news highlights a $1.4B partnership with CareTrust REIT and institutional buying interest.
Outlook remains positive with analyst consensus price target of $74.00 (10.5% upside) and no sell ratings. Key risks include rising debt levels (debt-to-asset ratio up to 48.48% in 2025) and execution of $13.4B capital expenditure plan. The stock offers defensive utility exposure with 23-year dividend growth.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
